Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
28.19
+1.32 (4.91%)
At close: Feb 24, 2026, 4:00 PM EST
28.75
+0.56 (1.99%)
After-hours: Feb 24, 2026, 7:38 PM EST
HRMY Employees
Harmony Biosciences Holdings had 268 employees as of December 31, 2024. The number of employees increased by 22 or 8.94% compared to the previous year.
Employees
268
Change (1Y)
22
Growth (1Y)
8.94%
Revenue / Employee
$3,240,496
Profits / Employee
$592,116
Market Cap
1.62B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 268 | 22 | 8.94% |
| Dec 31, 2023 | 246 | 46 | 23.00% |
| Dec 31, 2022 | 200 | 20 | 11.11% |
| Dec 31, 2021 | 180 | 30 | 20.00% |
| Dec 31, 2020 | 150 | 0 | - |
| Sep 30, 2020 | 150 | 0 | - |
| Jun 30, 2020 | 150 | - | - |
| Mar 31, 2020 | 150 | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Ardelyx | 489 |
| MannKind | 407 |
| Intellia Therapeutics | 403 |
| Nurix Therapeutics | 317 |
| Biohaven | 256 |
| Relay Therapeutics | 188 |
| Celldex Therapeutics | 186 |
| Enliven Therapeutics | 65 |
HRMY News
- 4 hours ago - Harmony Biosciences Holdings, Inc. (HRMY) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 12 hours ago - Harmony Biosciences Reports Strong 2025 Financial Results and Reiterates 2026 Net Revenue Guidance of Over $1 Billion - Business Wire
- 7 days ago - Harmony Biosciences Receives U.S. Food and Drug Administration Approval for WAKIX® (pitolisant) for the Treatment of Cataplexy in Pediatric Narcolepsy - Business Wire
- 14 days ago - Harmony Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 - Business Wire
- 5 weeks ago - Harmony Biosciences Holdings, Inc. (HRMY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 6 weeks ago - Harmony Biosciences Guides to Over $1 Billion in WAKIX® Revenue in 2026; Advancing Robust Late-Stage Pipeline With Potential for Long-term Value Creation - Business Wire
- 6 weeks ago - Harmony Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference - Business Wire
- 2 months ago - Beacon Biosignals Announces Partnership with Harmony Biosciences to Advance Objective Clinical Endpoints in Hypersomnia Conditions Through Quantitative EEG - GlobeNewsWire